AstraZeneca Changes Name of Vaccine

The European Medicines Agency approved the change on March 25.

Grow Your Business, Not Your Inbox

Stay informed and join our daily newsletter now!
Entrepreneur Staff
1 min read
This article was translated from our Spanish edition using AI technologies. Errors may exist due to this process.

The British-Swedish pharmaceutical AstraZeneca announced that the COVID-19 vaccine, in conjunction with the British University of Oxford, has been renamed Vaxzevria.

As reported in The Brussels Times, the name change was approved on March 25 following a request from the company and was announced on the website of the European Medicines Agency (EMA) and that of the Swedish National Medicines Agency (Läkemedelsverket).

The new name does not imply a change in the formula of the vaccine, according to the Läkemedelsverket, but there will be a new labeling and packaging of the drug.

For its part, the EMA recalled that the Vaxzevria vaccine is safe in people over 18 years of age, but that it has reduced its effectiveness from 79 to 76 percent.

More from Entrepreneur
Entrepreneur Select: A Fund For Entrepreneurs, By Entrepreneurs

Entrepreneurs require more than just money, which is why we aim to empower you, as well as act as a catalyst for value creation.

Entrepreneur Insider members enjoy exclusive access to business resources for just $5/mo:
  • Premium articles, videos, and webinars
  • An ad-free experience
  • A weekly newsletter
  • Bonus: A FREE 1-year Entrepreneur magazine subscription delivered directly to you
Make sure you’re covered for physical injuries or property damage that occur at work by
  • Providing us with basic information about your business
  • Verifying details about your business with one of our specialists
  • Speaking with an agent who is specifically suited to insure your business

Latest on Entrepreneur